Indaptus Therapeutics Future Growth
Future criteria checks 0/6
Indaptus Therapeutics is forecast to grow earnings and revenue by 13.7% and 79.9% per annum respectively while EPS is expected to grow by 28.3% per annum.
Key information
13.7%
Earnings growth rate
28.3%
EPS growth rate
| Biotechs earnings growth | 24.8% |
| Revenue growth rate | 79.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 May 2024 |
Recent future growth updates
Recent updates
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Invest In Growth?
Mar 27
Is Indaptus Therapeutics (NASDAQ:INDP) In A Good Position To Deliver On Growth Plans?
Aug 15Indaptus Therapeutics GAAP EPS of -$0.46 beats by $0.45
Aug 08Indaptus Therapeutics: Advancing Decoy Technology To Address Cancer And Viral Indications
Sep 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -23 | N/A | N/A | 1 |
| 12/31/2025 | N/A | -24 | N/A | N/A | 2 |
| 12/31/2024 | N/A | -21 | N/A | N/A | 2 |
| 3/31/2024 | N/A | -15 | -12 | -12 | N/A |
| 12/31/2023 | N/A | -15 | -13 | -13 | N/A |
| 9/30/2023 | N/A | -15 | -13 | -13 | N/A |
| 6/30/2023 | N/A | -15 | -14 | -14 | N/A |
| 3/31/2023 | N/A | -15 | -15 | -15 | N/A |
| 12/31/2022 | N/A | -14 | -13 | -13 | N/A |
| 9/30/2022 | N/A | -14 | -14 | -14 | N/A |
| 6/30/2022 | N/A | -14 | -15 | -15 | N/A |
| 3/31/2022 | N/A | -10 | -14 | -14 | N/A |
| 12/31/2021 | N/A | -8 | -11 | -11 | N/A |
| 9/30/2021 | N/A | -5 | -9 | -9 | N/A |
| 6/30/2021 | N/A | -3 | -4 | -4 | N/A |
| 3/31/2021 | N/A | -4 | -4 | -4 | N/A |
| 12/31/2020 | N/A | -4 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INDP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: INDP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: INDP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: INDP is forecast to have no revenue next year.
High Growth Revenue: INDP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if INDP's Return on Equity is forecast to be high in 3 years time